Gene · 5803
Papers1,425
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 1,425
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastoma. | Cancer Commun (Lond) | 2023 | 37920878 | PubTator, text mining | PubMed |
| Patient Brain Organoids Identify a Link between the 16p11.2 Copy Number Variant and the RBFOX1 Gene. | ACS Chem Neurosci | 2023 | 37903506 | PubTator, text mining | PubMed |
| Molecular and Cellular Insights: A Focus on Glycans and the HNK1 Epitope in Autism Spectrum Disorder. | Int J Mol Sci | 2023 | 37894820 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cell Transplantation: Neuroprotection and Nerve Regeneration After Spinal Cord Injury. | J Inflamm Res | 2023 | 37881652 | PubTator, text mining | PubMed |
| Crosstalk between m6A modification and alternative splicing during cancer progression. | Clin Transl Med | 2023 | 37850412 | PubTator, text mining | PubMed |
| Differential Production of Midkine and Pleiotrophin by Innate APCs upon Stimulation through Nucleic Acid-Sensing TLRs. | J Immunol Res | 2023 | 37850119 | PubTator, text mining | PubMed |
| Pyroptosis-related gene signatures are associated with prognosis and tumor microenvironment infiltration in head and neck cancer. | Health Sci Rep | 2023 | 37841942 | PubTator, text mining | PubMed |
| Nasopharynx Battlefield: Cellular Immune Responses Mediated by Midkine in Nasopharyngeal Carcinoma and COVID-19. | Cancers (Basel) | 2023 | 37835544 | PubTator, text mining | PubMed |
| Comparative transcriptomics reveals human-specific cortical features. | Science | 2023 | 37824638 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model. | Front Oncol | 2023 | 37817770 | PubTator, text mining | PubMed |
| Analyzing alternative splicing in Alzheimer's disease postmortem brain: a cell-level perspective. | Front Mol Neurosci | 2023 | 37799732 | PubTator, text mining | PubMed |
| Reduced length of nodes of Ranvier and altered proteoglycan immunoreactivity in prefrontal white matter in major depressive disorder and chronically stressed rats. | Sci Rep | 2023 | 37775676 | PubTator, text mining | PubMed |
| An Observatory for the MET Oncogene: A Guide for Targeted Therapies. | Cancers (Basel) | 2023 | 37760640 | PubTator, text mining | PubMed |
| Celf4 controls mRNA translation underlying synaptic development in the prenatal mammalian neocortex. | Nat Commun | 2023 | 37758766 | PubTator, text mining | PubMed |
| The diversity and dynamics of tumor-associated macrophages in recurrent glioblastoma. | Front Immunol | 2023 | 37731483 | PubTator, text mining | PubMed |
| Role of IL-34 and its receptors in inflammatory diseases. | Cytokine | 2023 | 37683444 | PubTator, text mining | PubMed |
| The combined signatures of telomere and immune cell landscape provide a prognostic and therapeutic biomarker in glioma. | Front Immunol | 2023 | 37662954 | PubTator, text mining | PubMed |
| Identification of cancer stemness and M2 macrophage-associated biomarkers in lung adenocarcinoma. | Heliyon | 2023 | 37662825 | PubTator, text mining | PubMed |
| Role of long non-coding RNAs in cancer: From subcellular localization to nanoparticle-mediated targeted regulation. | Mol Ther Nucleic Acids | 2023 | 37655045 | PubTator, text mining | PubMed |
| Editorial: Deciphering the etiology of rare genetic disorders associated with protein phosphatases. | Front Cell Dev Biol | 2023 | 37645249 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5803/papers?page=7